<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vavilov</journal-id><journal-title-group><journal-title xml:lang="ru">Вавиловский журнал генетики и селекции</journal-title><trans-title-group xml:lang="en"><trans-title>Vavilov Journal of Genetics and Breeding</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2500-3259</issn><publisher><publisher-name>Institute of Cytology and Genetics of Siberian Branch of the RAS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/VJ18.381</article-id><article-id custom-type="elpub" pub-id-type="custom">vavilov-1548</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕДИЦИНСКАЯ ГЕНЕТИКА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MEDICAL GENETICS</subject></subj-group></article-categories><title-group><article-title>АССОЦИАЦИЯ ПОЛИМОРФИЗМА  ГЕНОВ 2′-5′-ОЛИГОАДЕНИЛАТСИНТЕТАЗ  С УРОВНЕМ ГУМОРАЛЬНОГО ИММУННОГО ОТВЕТА ПОСЛЕ ВАКЦИНАЦИИ  ПРОТИВ КЛЕЩЕВОГО ЭНЦЕФАЛИТА</article-title><trans-title-group xml:lang="en"><trans-title>ASSOCIATION BETWEEN POLYMORPHISMS IN GENES ENCODING 2′-5′-OLIGOADENYLATE SYNTHETASES  AND THE HUMORAL IMMUNE RESPONSE UPON VACCINATION AGAINST TICK-BORNE ENCEPHALITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юдин</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Yudin</surname><given-names>N. S.</given-names></name></name-alternatives><email xlink:type="simple">yudin@bionet.nsc.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Игошин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Igoshin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лутова</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Lutova</surname><given-names>S. L.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гон</surname><given-names>Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Gon</surname><given-names>Ya.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воевода</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Voevoda</surname><given-names>M. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белявская</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Belyavskaya</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новосибирская область,  р. п. Кольцово</p></bio><bio xml:lang="en"><p>Novosibirsk region, Koltsovo</p></bio><xref ref-type="aff" rid="aff-5"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук; Новосибирский национальный исследовательский государственный университет; Научно-исследовательский институт терапии и профилактической медицины – филиал Федерального исследовательского центра  Институт цитологии и генетики Сибирского отделения Российской академии наук<country>Россия</country></aff><aff xml:lang="en">Institute of Cytology and Genetics SB RAS; Novosibirsk State University; Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy  of Sciences<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук<country>Россия</country></aff><aff xml:lang="en">Institute of Cytology and Genetics SB RAS<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">Государственное бюджетное учреждение здравоохранения Новосибирской области «Городская поликлиника № 14»<country>Россия</country></aff><aff xml:lang="en">State Budgetary Health Care Institution of the Novosibirsk Region “City Hospital № 14”<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">Новосибирский национальный исследовательский государственный университет<country>Россия</country></aff><aff xml:lang="en">Novosibirsk State University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru">Государственный научный центр вирусологии и биотехнологии «Вектор» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека<country>Россия</country></aff><aff xml:lang="en">State Research Center of Virology and Biotechnology “Vector” of the Federal Service for Surveillance in Consumer Rights Protection and Human Well-being<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>04</day><month>07</month><year>2018</year></pub-date><volume>22</volume><issue>4</issue><fpage>445</fpage><lpage>451</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Юдин Н.С., Игошин А.В., Лутова С.Л., Гон Я., Воевода М.И., Белявская В.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Юдин Н.С., Игошин А.В., Лутова С.Л., Гон Я., Воевода М.И., Белявская В.А.</copyright-holder><copyright-holder xml:lang="en">Yudin N.S., Igoshin A.V., Lutova S.L., Gon Y., Voevoda M.I., Belyavskaya V.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vavilov.elpub.ru/jour/article/view/1548">https://vavilov.elpub.ru/jour/article/view/1548</self-uri><abstract><p>Вакцинация является эффективным средством профилактики клещевого энцефалита, формирующим активный иммунитет. Однако избыточная иммунизация при вакцинации неоправданна с точки зрения экономики и медицинской этики. Одним из подходов к индивидуализации вакцинации может быть подбор доз вакцины в зависимости от ожидаемого уровня иммунного ответа пациента. Поэтому возникает необходимость разработки методов оценки потенциального уровня иммунологических реакций человека до проведения вакцинации. Цель работы – поиск возможных ассоциаций однонуклеотидных полиморфных маркеров (ОНП) в генах OAS2 и OAS3, для которых ранее была найдена корреляция с развитием тяжелых форм клещевого энцефалита, а также с образованием антител и  цитокинов после вакцинации против клещевого энцефалита. В исследовании приняли участие 97 добровольцев обоего пола, ранее не вакцинированных и не имевших контактов с клещами. Через один месяц после иммунизации вакциной « ЭнцеВир» у них брали пробы венозной крови. Анализировали уровни специфических антител IgG против вируса клещевого энцефалита и интерлейкина 4 (ИЛ-4). Генотипировали ОНП rs2285932, rs2072136, rs1293762, rs15895 и rs1732778 в генах 2’-5’-олигоаденилатсинтетаз OAS2 и OAS3. Выработка антител в ответ на введение вакцины была достоверно ассоциирована с ОНП rs1732778 в регуляторном районе гена OAS2. Этот показатель оказался существенно выше у людей с гетерозиготным генотипом G/A , чем у субъектов с гомозиготными генотипами G/G и A/A. Индивиды-носители аллеля А в составе генотипов G/A и A/A этого же ОНП имели сниженный уровень ИЛ-4 по сравнению с гомозиготными индивидами G/G. Полученные нами результаты свидетельствуют о том, что ОНП rs1732778 в регуляторной области гена OAS2 ассоциирован с образованием противовирусных антител IgG и уровнем ИЛ-4 после вакцинации. По-видимому, генетический полиморфизм в гене OAS2 следует принимать во внимание при индивидуализации вакцинопрофилактики клещевого энцефалита.</p></abstract><trans-abstract xml:lang="en"><p>Vaccination forms active immunity and represents an effective way of preventing tick-borne encephalitis (TBE). However, excessive vaccination is unjustified in terms of economics and medical ethics. One of the individualized approaches to vaccines is the selection of vaccine doses depending on the expected levels of immune response. Therefore, there is a need for new methods for assessing potential human immune responses prior to vaccination. The aim of this study was to determine possible association between single nucleotide polymorphisms (SNPs) located within OAS2 and OAS3 genes, which have been previously associated with the development of severe forms of TBE, and the formation of antibodies and cytokines upon vaccination against TBE. The study involved 97 volunteers of both sexes who had not previously been vaccinated against TBE and had no contact with ticks. Venous blood samples were collected one month after vaccination against TBE using the EnceVir vaccine. Levels of specific IgG antibodies against tick-borne encephalitis virus and interleukin 4 (IL-4) were analyzed. Genomic DNA samples were genotyped for the SNPs rs2285932, rs2072136, rs1293762, rs15895 and rs1732778 in genes encoding 2’-5’-oligoadenylate synthetases OAS2 and OAS3. Antibody production in response to vaccine administration was significantly associated with SNP rs1732778 in the regulatory region of the OAS2 gene. This indicator was significantly higher in people with heterozygous genotypes G/A as compared to people with homozygous genotypes G/G and A/A. Carriers of the A allele (G/A or A/A genotypes) of the same SNP had reduced IL-4 levels as compared to the homozygous G/G individuals. Thus, the data obtained indicate that SNP rs1732778 in the regulatory region of the OAS2 gene correlates with the formation of antiviral IgG antibodies and changes in IL-4 levels upon vaccination. Evidently, the genetic polymorphism in OAS2 gene should be considered when performing individualized TBE vaccinations.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>клещевой энцефалит</kwd><kwd>вакцинация</kwd><kwd>IgG антитела</kwd><kwd>ген</kwd><kwd>OAS2</kwd><kwd>OAS3</kwd><kwd>однонуклеотидный полиморфизм</kwd><kwd>ассоциация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tick-borne encephalitis</kwd><kwd>vaccination</kwd><kwd>IgG antibodies</kwd><kwd>gene</kwd><kwd>OAS2</kwd><kwd>OAS3</kwd><kwd>single nucleotide polymorphism</kwd><kwd>association</kwd></kwd-group><funding-group xml:lang="en"><funding-statement>Russian Science Foundation grant (project 16-15-00127)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Alagarasu K., Honap T., Damle I.M., Mulay A.P., Shah P.S., Cecilia D. Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection. Infect. Genet. Evol. 2013;14:390-395. DOI 10.1016/j.meegid.2012.12.021.</mixed-citation><mixed-citation xml:lang="en">Alagarasu K., Honap T., Damle I.M., Mulay A.P., Shah P.S., Cecilia D. Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection. Infect. Genet. Evol. 2013;14:390-395. DOI 10.1016/j.meegid.2012.12.021.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-TeKippe E., Taxman D.J., Guthrie E.H., Pickles R.J., Ting J.P. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009;30:556-565.</mixed-citation><mixed-citation xml:lang="en">Allen I.C., Scull M.A., Moore C.B., Holl E.K., McElvania-TeKippe E., Taxman D.J., Guthrie E.H., Pickles R.J., Ting J.P. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009;30:556-565.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Barkhash A.V., Babenko V.N., Kobzev V.F., Romashchenko A.G., Voe voda M.I. Polymorphism in the human 2′-5′-oligoadenylate synthetase genes (OAS), associated with predisposition to severe forms of tick-borne ence phalitis, in populations from North Eurasia. Molekulyarnaya Bio lo giya = Molecular Biology (Moscow). 2010;44:985-993.(in Russian)</mixed-citation><mixed-citation xml:lang="en">Barkhash A.V., Babenko V.N., Kobzev V.F., Romashchenko A.G., Voe voda M.I. Polymorphism in the human 2′-5′-oligoadenylate synthetase genes (OAS), associated with predisposition to severe forms of tick-borne ence phalitis, in populations from North Eurasia. Molekulyarnaya Bio lo giya = Molecular Biology (Moscow). 2010;44:985-993.(in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Barkhash A.V., Perelygin A.A., Babenko V.N., Myasnikova N.G., Pilipenko P.I., Romaschenko A.G., Voevoda M.I., Brinton M.A. Variability in the 2′-5′-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. J. Infect. Dis. 2010;202(12):1813-1818. DOI 10.1086/657418.</mixed-citation><mixed-citation xml:lang="en">Barkhash A.V., Perelygin A.A., Babenko V.N., Myasnikova N.G., Pilipenko P.I., Romaschenko A.G., Voevoda M.I., Brinton M.A. Variability in the 2′-5′-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. J. Infect. Dis. 2010;202(12):1813-1818. DOI 10.1086/657418.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bigham A.W., Buckingham K.J., Husain S., Emond M.J., Bofferding K.M., Gildersleeve H., Rutherford A., Astakhova N.M., Perelygin A.A., Busch M.P., Murray K.O., Sejvar J.J., Green S., Kriesel J., Brinton M.A., Bamshad M. Host genetic risk factors for West Nile virus infection and disease progression. PLoS One. 2011;6(9):e24745. DOI 10.1371/journal.pone.0024745.</mixed-citation><mixed-citation xml:lang="en">Bigham A.W., Buckingham K.J., Husain S., Emond M.J., Bofferding K.M., Gildersleeve H., Rutherford A., Astakhova N.M., Perelygin A.A., Busch M.P., Murray K.O., Sejvar J.J., Green S., Kriesel J., Brinton M.A., Bamshad M. Host genetic risk factors for West Nile virus infection and disease progression. PLoS One. 2011;6(9):e24745. DOI 10.1371/journal.pone.0024745.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bilalova G.P. Issues of the practical use of Encevir vaccine. Sibirskiy Medi tsinskiy Zhurnal = Siberian Medical Journal. 2009;2:86-91. (in Russian)</mixed-citation><mixed-citation xml:lang="en">Bilalova G.P. Issues of the practical use of Encevir vaccine. Sibirskiy Medi tsinskiy Zhurnal = Siberian Medical Journal. 2009;2:86-91. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Danial-Farran N., Eghbaria S., Schwartz N., Kra-Oz Z., Bisharat N. Genetic variants associated with susceptibility of Ashkenazi Jews to West Nile virus infection. Epidemiol. Infect. 2015;143:857-863. DOI 10.1017/S0950268814001290.</mixed-citation><mixed-citation xml:lang="en">Danial-Farran N., Eghbaria S., Schwartz N., Kra-Oz Z., Bisharat N. Genetic variants associated with susceptibility of Ashkenazi Jews to West Nile virus infection. Epidemiol. Infect. 2015;143:857-863. DOI 10.1017/S0950268814001290.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dugan J.W., Albor A., David L., Fowlkes J., Blackledge M.T., Martin T.M., Planck S.R., Rosenzweig H.L., Rosenbaum J.T., Davey M.P. Nucleotide oligomerization domain-2 interacts with 2′-5′-oligoadenylate synthetase type 2 and enhances RNase-L function in THP-1 cells. Mol. Immunol. 2009;47(2-3):560-566. DOI 10.1016/j.molimm.2009.09.025.</mixed-citation><mixed-citation xml:lang="en">Dugan J.W., Albor A., David L., Fowlkes J., Blackledge M.T., Martin T.M., Planck S.R., Rosenzweig H.L., Rosenbaum J.T., Davey M.P. Nucleotide oligomerization domain-2 interacts with 2′-5′-oligoadenylate synthetase type 2 and enhances RNase-L function in THP-1 cells. Mol. Immunol. 2009;47(2-3):560-566. DOI 10.1016/j.molimm.2009.09.025.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gadani S.P., Cronk J.C., Norris G.T., Kipnis J. IL-4 in the brain: a cytokine to remember. J. Immunol. 2012;189:4213-4219. DOI 10.4049/jimmunol.1202246.</mixed-citation><mixed-citation xml:lang="en">Gadani S.P., Cronk J.C., Norris G.T., Kipnis J. IL-4 in the brain: a cytokine to remember. J. Immunol. 2012;189:4213-4219. DOI 10.4049/jimmunol.1202246.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Geha R.S., Jabara H.H., Brodeur S.R. The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 2003;3: 721-732.</mixed-citation><mixed-citation xml:lang="en">Geha R.S., Jabara H.H., Brodeur S.R. The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 2003;3: 721-732.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003;3:23-35</mixed-citation><mixed-citation xml:lang="en">Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003;3:23-35</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gröndahl-Yli-Hannuksela K., Vahlberg T., Ilonen J., Mertsola J., He Q. Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults. Immunogenetics. 2016;68:733-741. DOI 10.1007/s00251016-0923-0.</mixed-citation><mixed-citation xml:lang="en">Gröndahl-Yli-Hannuksela K., Vahlberg T., Ilonen J., Mertsola J., He Q. Polymorphism of IL-10 gene promoter region: association with T cell proliferative responses after acellular pertussis vaccination in adults. Immunogenetics. 2016;68:733-741. DOI 10.1007/s00251016-0923-0.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Haralambieva I.H., Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. 2′-5′-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum. Immunol. 2010;71:383-391. DOI 10.1016/j.humimm.2010.01.004.</mixed-citation><mixed-citation xml:lang="en">Haralambieva I.H., Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. 2′-5′-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum. Immunol. 2010;71:383-391. DOI 10.1016/j.humimm.2010.01.004.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hovanessian A.G., Justesen J. The human 2′-5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation. Biochimie. 2007;89: 779-788.</mixed-citation><mixed-citation xml:lang="en">Hovanessian A.G., Justesen J. The human 2′-5′oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation. Biochimie. 2007;89: 779-788.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ierusalimsky A.P. Tick-Borne Encephalitis: Manual for Physicians. Novosibirsk: State Medical Academy Publ., 2001. (in Russian)</mixed-citation><mixed-citation xml:lang="en">Ierusalimsky A.P. Tick-Borne Encephalitis: Manual for Physicians. Novosibirsk: State Medical Academy Publ., 2001. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Imran M., Manzoor S., Khattak N.M., Tariq M., Khalid M., Javed F., Bhatti S. Correlation of OAS1 gene polymorphism at exon 7 splice accepter site with interferon-based therapy of HCV infection in Pakistan. Viral Immunol. 2014;27:105-111. DOI 10.1089/vim.2013.0107.</mixed-citation><mixed-citation xml:lang="en">Imran M., Manzoor S., Khattak N.M., Tariq M., Khalid M., Javed F., Bhatti S. Correlation of OAS1 gene polymorphism at exon 7 splice accepter site with interferon-based therapy of HCV infection in Pakistan. Viral Immunol. 2014;27:105-111. DOI 10.1089/vim.2013.0107.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kristiansen H., Gad H.H., Eskildsen-Larsen S., Despres P., Hartmann R. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J. Interferon Cytokine Res. 2011;31:41-47. DOI 10.1089/jir.2010.0107.</mixed-citation><mixed-citation xml:lang="en">Kristiansen H., Gad H.H., Eskildsen-Larsen S., Despres P., Hartmann R. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J. Interferon Cytokine Res. 2011;31:41-47. DOI 10.1089/jir.2010.0107.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lim J.K., Lisco A., McDermott D.H., Huynh L., Ward J.M., Johnson B., Johnson H., Pape J., Foster G.A., Krysztof D., Follmann D., Stramer S.L., Margolis L.B., Murphy P.M. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009;5:e1000321. DOI 10.1371/journal.ppat.1000321.</mixed-citation><mixed-citation xml:lang="en">Lim J.K., Lisco A., McDermott D.H., Huynh L., Ward J.M., Johnson B., Johnson H., Pape J., Foster G.A., Krysztof D., Follmann D., Stramer S.L., Margolis L.B., Murphy P.M. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009;5:e1000321. DOI 10.1371/journal.ppat.1000321.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Linnik J.E., Egli A. Impact of host genetic polymorphisms on vaccine induced antibody response. Hum. Vaccin. Immunother. 2016;12:907915. DOI 10.1080/21645515.2015.1119345.</mixed-citation><mixed-citation xml:lang="en">Linnik J.E., Egli A. Impact of host genetic polymorphisms on vaccine induced antibody response. Hum. Vaccin. Immunother. 2016;12:907915. DOI 10.1080/21645515.2015.1119345.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lutova S.L., Tumanov Yu.V., Voevoda M.I., Belyavskaya V.A. Tickborne encephalitis and vaccines: genetic and physiological factors influencing the functional activity of specific antibodies. Proceedings of the Scientific and Practical Conference. Novosibirsk, 2016;191-193. (in Russian)</mixed-citation><mixed-citation xml:lang="en">Lutova S.L., Tumanov Yu.V., Voevoda M.I., Belyavskaya V.A. Tickborne encephalitis and vaccines: genetic and physiological factors influencing the functional activity of specific antibodies. Proceedings of the Scientific and Practical Conference. Novosibirsk, 2016;191-193. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Meduni tsin N.V. Vaccinology. Moscow: Triada-Х Publ., 2004. (in Russian)</mixed-citation><mixed-citation xml:lang="en">Meduni tsin N.V. Vaccinology. Moscow: Triada-Х Publ., 2004. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 2001;276:4812-4818. DOI 10.1074/jbc.M008072200.</mixed-citation><mixed-citation xml:lang="en">Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 2001;276:4812-4818. DOI 10.1074/jbc.M008072200.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Poland G.A., Kennedy R.B., Ovsyannikova I.G. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? PLoS Pathog. 2011;7:e1002344.</mixed-citation><mixed-citation xml:lang="en">Poland G.A., Kennedy R.B., Ovsyannikova I.G. Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? PLoS Pathog. 2011;7:e1002344.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Poland G.A., Ovsyannikova I.G., Jacobson R.M. Vaccine immunogenetics: bedside to bench to population. Vaccine. 2008;26:6183-6188.</mixed-citation><mixed-citation xml:lang="en">Poland G.A., Ovsyannikova I.G., Jacobson R.M. Vaccine immunogenetics: bedside to bench to population. Vaccine. 2008;26:6183-6188.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pulendran B., Miller J., Querec T.D., Akondy R., Moseley N., Laur O., Glidewell J., Monson N., Zhu T., Zhu H., Staprans S., Lee D., Brinton M.A., Perelygin A.A., Vellozzi C., Brachman P. Jr., Lalor S., Teuwen D., Eidex R.B., Cetron M., Priddy F., del Rio C., Altman J., Ahmed R. Case of yellow fever vaccine – associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J. Infect. Dis. 2008;198:500-507. DOI 10.1086/590187.</mixed-citation><mixed-citation xml:lang="en">Pulendran B., Miller J., Querec T.D., Akondy R., Moseley N., Laur O., Glidewell J., Monson N., Zhu T., Zhu H., Staprans S., Lee D., Brinton M.A., Perelygin A.A., Vellozzi C., Brachman P. Jr., Lalor S., Teuwen D., Eidex R.B., Cetron M., Priddy F., del Rio C., Altman J., Ahmed R. Case of yellow fever vaccine – associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J. Infect. Dis. 2008;198:500-507. DOI 10.1086/590187.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Sambrook J., Russell D.W. The condensed protocols from Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 2006.</mixed-citation><mixed-citation xml:lang="en">Sambrook J., Russell D.W. The condensed protocols from Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 2006.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Sanda C., Weitzel P., Tsukahara T., Schaley J., Edenberg H.J., Stephens M.A., McClintick J.N., Blatt L.M., Li L., Brodsky L., Taylor M.W. Differential gene induction by type I and type II inter ferons and their combination. J. Interferon Cytokine Res. 2006;26:462-472.</mixed-citation><mixed-citation xml:lang="en">Sanda C., Weitzel P., Tsukahara T., Schaley J., Edenberg H.J., Stephens M.A., McClintick J.N., Blatt L.M., Li L., Brodsky L., Taylor M.W. Differential gene induction by type I and type II inter ferons and their combination. J. Interferon Cytokine Res. 2006;26:462-472.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Thamizhmani R., Vijayachari P. Association of dengue virus infection susceptibility with polymorphisms of 2′-5′-oligoadenylatesynthetase genes: a case-control study. Braz. J. Infect. Dis. 2014;18:548550.</mixed-citation><mixed-citation xml:lang="en">Thamizhmani R., Vijayachari P. Association of dengue virus infection susceptibility with polymorphisms of 2′-5′-oligoadenylatesynthetase genes: a case-control study. Braz. J. Infect. Dis. 2014;18:548550.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">UCSC Genome Browser Gateway. 2017. Available at http://genome– euro.ucsc.edu/cgi–bin/hgGateway?hgsid=225788287_h9nI4RnxWsBd3VHZFAl6jALan0UJ.</mixed-citation><mixed-citation xml:lang="en">UCSC Genome Browser Gateway. 2017. Available at http://genome– euro.ucsc.edu/cgi–bin/hgGateway?hgsid=225788287_h9nI4RnxWsBd3VHZFAl6jALan0UJ.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Valarcher J.F., Hägglund S., Juremalm M., Blomqvist G., Renström L., Zohari S., Leijon M., Chirico J. Tick-borne encephalitis. Rev. Sci. Tech. 2015;34:453-466.</mixed-citation><mixed-citation xml:lang="en">Valarcher J.F., Hägglund S., Juremalm M., Blomqvist G., Renström L., Zohari S., Leijon M., Chirico J. Tick-borne encephalitis. Rev. Sci. Tech. 2015;34:453-466.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Vector-Best Company. Reagents for cytokine analysis. 2004. Available at http://www.cytokines.ru/2004/4/Art12.php. (in Russian)</mixed-citation><mixed-citation xml:lang="en">Vector-Best Company. Reagents for cytokine analysis. 2004. Available at http://www.cytokines.ru/2004/4/Art12.php. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Yakub I., Lillibridge K.M., Moran A., Gonzalez O.Y., Belmont J., Gibbs R.A., Tweardy D.J. Single nucleotide polymorphisms in genes for 2′-5′-oligoadenylatesynthetase and RNase L in patients hospitalized with West Nile virus infection. J. Infect. Dis. 2005;192: 1741-1748.</mixed-citation><mixed-citation xml:lang="en">Yakub I., Lillibridge K.M., Moran A., Gonzalez O.Y., Belmont J., Gibbs R.A., Tweardy D.J. Single nucleotide polymorphisms in genes for 2′-5′-oligoadenylatesynthetase and RNase L in patients hospitalized with West Nile virus infection. J. Infect. Dis. 2005;192: 1741-1748.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Yudin N.S., Barkhash A.V., Maksimov V.N., Ignatieva E.V., Romaschenko A.G. Human genetic predisposition to diseases caused by viruses from Flaviviridae fa mily. Molecular Biology (Moscow). 2018;52:165-181.</mixed-citation><mixed-citation xml:lang="en">Yudin N.S., Barkhash A.V., Maksimov V.N., Ignatieva E.V., Romaschenko A.G. Human genetic predisposition to diseases caused by viruses from Flaviviridae fa mily. Molecular Biology (Moscow). 2018;52:165-181.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Zamorano J., Rivas M.D., Pérez M. Interleukin-4: A multifunctional cytokine. Inmunologia. 2003;22:215-224.</mixed-citation><mixed-citation xml:lang="en">Zamorano J., Rivas M.D., Pérez M. Interleukin-4: A multifunctional cytokine. Inmunologia. 2003;22:215-224.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
